首页> 美国卫生研究院文献>Nanomaterials >Polydopamine-Coated Laponite Nanoplatforms for Photoacoustic Imaging-Guided Chemo-Phototherapy of Breast Cancer
【2h】

Polydopamine-Coated Laponite Nanoplatforms for Photoacoustic Imaging-Guided Chemo-Phototherapy of Breast Cancer

机译:聚德莫胺涂覆的丙龙纳米纳薄形成用于光声成像引导的乳腺癌光学疗法

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Theranostic nanoplatforms combining photosensitizers and anticancer drugs have aroused wide interest due to the real-time photoacoustic (PA) imaging capability and improved therapeutic efficacy by the synergistic effect of chemotherapy and phototherapy. In this study, polydopamine (PDA) coated laponite (LAP) nanoplatforms were synthesized to efficiently load indocyanine green (ICG) and doxorubicin (DOX), and modified with polyethylene glycol-arginine-glycine-aspartic acid (PEG-RGD) for PA imaging-guided chemo-phototherapy of cancer cells overexpressing αvβ3 integrin. The formed ICG/LAP-PDA-PEG-RGD/DOX nanoplatforms showed significantly higher photothermal conversion efficiency than ICG solution and excellent PA imaging capability, and could release DOX in a pH-sensitive and NIR laser-triggered way, which is highly desirable feature in precision chemotherapy. In addition, the ICG/LAP-PDA-PEG-RGD/DOX nanoplatforms could be uptake by cancer cells overexpressing αvβ3 integrin with high specificity, and thus serve as a targeted contrast agent for in vivo PA imaging of cancer. In vivo experiments with 4T1 tumor-bearing mouse model demonstrated that ICG/LAP-PDA-PEG-RGD/DOX nanoplatforms exhibited much stronger therapeutic effect and higher survival rate than monotherapy due to the synergetic chemo-phototherapy under NIR laser irradiation. Therefore, the reported ICG/LAP-PDA-PEG-RGD/DOX represents a promising theranostic nanoplatform for high effectiveness PA imaging-guided chemo-phototherapy of cancer cells overexpressing αvβ3 integrin.
机译:由于实时光声(PA)成像能力和化疗和光疗协同效应改善了治疗效果,因此,由于实时光声(PA)成像能力和改善的治疗效率,其抗炎纳米纳薄物均呼吁广泛兴趣。在该研究中,合成了多碳胺(PDA)涂覆的丙酮(LAP)纳米载物(LAP)纳米载物,以有效地载入吲​​哚菁绿(ICG)和多柔比星(DOX),并用用于PA成像的聚乙二醇 - 精氨酸 - 甘氨酸 - 天冬氨酸(PEG-RGD)改性 - 癌细胞过表达αvβ3整联蛋白的癌细胞化学光疗法。形成的ICG / LAP-PDA-PEG-RGD / DOX纳米纳薄型显着较高的光热转换效率比ICG溶液和优异的PA成像能力,并且可以以pH敏感和鼻激光触发方式释放DOX,这是非常理想的特征精密化疗。此外,ICG / LAP-PDA-PEG-RGD / DOX纳米纳薄晶体可以通过过表达αvβ3整联蛋白的癌细胞吸收,因此用作癌症的体内PA成像的靶向造影剂。在体内实验中具有4T1肿瘤小鼠模型的实验表明,由于NIR激光照射下的协同化学光疗,ICG / LAP-PDA-PEG-RGD / DOX纳米克纳纳薄表现出比单疗法更强的治疗效果和更高的存活率。因此,报道的ICG / LAP-PDA-PEG-RGD / DOX代表了高效PA成像引导的癌细胞过表达αvβ3整联蛋白的高效PA成像引导的化学光疗法的有前途的治疗纳米片。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号